Moreover, a rationally designed VGLL4-mimicking peptide significantly suppresses CRC progression in mouse model (APCmin/+ and xenograft) in which β-catenin is hyperactivated, exemplifying a potential targeted therapy pointing to the crosstalk node between Wnt and Hippo pathways. This evidence concerns the gene VGLL4 and colorectal carcinoma.